Trials / Sponsors / QBiotics Group Limited
QBiotics Group Limited
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma Soft Tissue Sarcoma | Phase 2 | 2023-04-13 |
| Active Not Recruiting | A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck Cancer Head and Neck Cancer | Phase 2 | 2022-11-03 |
| Terminated | A Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c Melanoma Melanoma | Phase 2 | 2022-03-09 |
| Terminated | A Trial of Tigilanol Tiglate in Combination With Pembrolizumab in Stage IIIB to IV M1c-melanoma Melanoma | Phase 1 / Phase 2 | 2021-05-07 |